Caxton Associates (New York)’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-927
| Closed | -$501K | – | 534 |
|
|
2024
Q1 | $501K | Buy |
+927
| New | +$501K | 0.03% | 319 |
|
|
2023
Q4 | – | Sell |
-3,911
| Closed | -$1.71M | – | 499 |
|
|
2023
Q3 | $1.71M | Sell |
3,911
-362
| -8% | -$158K | 0.24% | 69 |
|
|
2023
Q2 | $2.15M | Buy |
4,273
+2,927
| +217% | +$1.47M | 0.32% | 62 |
|
|
2023
Q1 | $673K | Buy |
+1,346
| New | +$673K | 0.1% | 211 |
|
|
2022
Q4 | – | Sell |
-4,823
| Closed | -$1.57M | – | 504 |
|
|
2022
Q3 | $1.57M | Buy |
4,823
+2,948
| +157% | +$960K | 0.21% | 33 |
|
|
2022
Q2 | $658K | Buy |
+1,875
| New | +$658K | 0.06% | 192 |
|
|
2022
Q1 | – | Sell |
-478
| Closed | -$315K | – | 566 |
|
|
2021
Q4 | $315K | Buy |
+478
| New | +$315K | 0.03% | 378 |
|
|
2021
Q2 | – | Sell |
-1,066
| Closed | -$522K | – | 504 |
|
|
2021
Q1 | $522K | Buy |
+1,066
| New | +$522K | 0.05% | 132 |
|
|
2019
Q3 | – | Sell |
-33,794
| Closed | -$9.31M | – | 456 |
|
|
2019
Q2 | $9.31M | Buy |
33,794
+31,178
| +1,192% | +$8.58M | 1.12% | 12 |
|
|
2019
Q1 | $585K | Buy |
2,616
+724
| +38% | +$162K | 0.09% | 115 |
|
|
2018
Q4 | $352K | Hold |
1,892
| – | – | 0.06% | 156 |
|
|
2018
Q3 | $472K | Buy |
+1,892
| New | +$472K | 0.03% | 197 |
|
|
2017
Q4 | – | Sell |
-1,700
| Closed | -$264K | – | 374 |
|
|
2017
Q3 | $264K | Sell |
1,700
-900
| -35% | -$140K | 0.01% | 404 |
|
|
2017
Q2 | $420K | Buy |
+2,600
| New | +$420K | 0.02% | 334 |
|